Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Cash Flows from Operating Activities:      
Net income   $ 825,294 $ 11,126,044
Adjustments to reconcile net income to net cash used in operating activities:      
Expensed offering costs   867,351  
Interest income on investments held in Trust Account   (6,205) (1,159,962)
Loss on sale of private placement warrants   2,880,000  
Change in fair value of warrant liabilities $ 1,440,000 (5,060,000) (13,820,000)
Change in fair value of promissory note - related party (8,200)   (8,200)
Changes in operating assets and liabilities:      
Prepaid expenses   (202,436) 99,756
Accounts payable and accrued expenses   24,960 3,104,276
Due to related parties   129  
Net cash used in operating activities   (670,907) (658,086)
Cash Flows from Investing Activities:      
Cash deposited in Trust Account   (200,000,000)  
Net cash used in investing activities   (200,000,000)  
Cash Flows from Financing Activities:      
Proceeds from issuance of Class B ordinary shares to Sponsor   25,000  
Proceeds from initial public offering, net of underwriter's discount paid   196,000,000  
Proceeds from sale of private placement warrants   6,000,000  
Offering costs paid   (462,687)  
Proceeds from promissory note - related party     200,000
Net cash provided by financing activities   201,562,313 200,000
Net change in cash   891,406 (458,086)
Cash - beginning of period   0 482,651
Cash - end of period $ 24,565 891,406 24,565
Supplemental disclosure of noncash investing and financing activities:      
Forgiveness of deferred underwriting fee payable     1,750,000
Deferred underwriting fee payable   7,000,000  
Offering costs included in accrued offering costs   7,780  
Forfeiture of Class B ordinary shares   75  
Remeasurement of Class A ordinary shares subject to possible redemption   $ 25,403,116 $ 1,170,411